China's first COVID-19 pill, Azvudine, approved by the country's health regulator in late July, has been included in the medical reimbursement list temporarily, according to a new COVID-19 treatment guideline.
The medical reimbursement list is a catalog of drugs covered under China's social security system.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3